MENU
+Compare
FULC
Stock ticker: NASDAQ
AS OF
Dec 18, 12:41 PM (EDT)
Price
$4.35
Change
-$0.19 (-4.19%)
Capitalization
244.88M

FULC Fulcrum Therapeutics Forecast, Technical & Fundamental Analysis

a clinical-stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.

Industry Biotechnology
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
a Summary for FULC with price predictions
Dec 17, 2024

FULC in upward trend: price rose above 50-day moving average on November 25, 2024

FULC moved above its 50-day moving average on November 25, 2024 date and that indicates a change from a downward trend to an upward trend. In of 31 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 27, 2024. You may want to consider a long position or call options on FULC as a result. In of 87 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for FULC just turned positive on November 22, 2024. Looking at past instances where FULC's MACD turned positive, the stock continued to rise in of 35 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for FULC crossed bullishly above the 50-day moving average on December 03, 2024. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where FULC advanced for three days, in of 281 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Oscillator demonstrated that the stock has entered the overbought zone. This may point to a price pull-back soon.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where FULC declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

FULC broke above its upper Bollinger Band on December 16, 2024. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for FULC entered a downward trend on November 11, 2024. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.927) is normal, around the industry mean (14.664). P/E Ratio (0.000) is within average values for comparable stocks, (87.689). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.783). FULC has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.012). P/S Ratio (3.457) is also within normal values, averaging (260.687).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. FULC’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. FULC’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
FULC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

FULC is expected to report earnings to fall 18.91% to -28 cents per share on February 27

Fulcrum Therapeutics FULC Stock Earnings Reports
Q4'24
Est.
$-0.28
Q3'24
Beat
by $0.05
Q2'24
Beat
by $1.28
Q1'24
Beat
by $0.01
Q4'23
Beat
by $0.03
The last earnings report on November 13 showed earnings per share of -34 cents, beating the estimate of -40 cents. With 287.56K shares outstanding, the current market capitalization sits at 244.88M.
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company, which develops new medicines and focuses on unlocking gene control mechanisms to develop small molecule therapies.

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
26 Landsdowne Street
Phone
+1 617 651-8851
Employees
76
Web
https://www.fulcrumtx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CMCRX43.38N/A
N/A
Calvert US Mid Cap Core Rspnb Idx R6
CMALX26.74-0.03
-0.11%
Crawford Multi-Asset Income
JBAVX30.23-0.13
-0.43%
JHancock Balanced R5
BMCAX24.41-0.11
-0.45%
BlackRock Advantage Large Cap Gr Inv A
RYMKX60.37-1.09
-1.77%
Rydex Russell 2000 1.5x Strategy H

FULC and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, FULC has been loosely correlated with ONCT. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if FULC jumps, then ONCT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FULC
1D Price
Change %
FULC100%
+2.71%
ONCT - FULC
55%
Loosely correlated
N/A
SLS - FULC
48%
Loosely correlated
-4.17%
ANNX - FULC
40%
Loosely correlated
-3.56%
VRDN - FULC
39%
Loosely correlated
-3.34%
MLTX - FULC
34%
Loosely correlated
+6.27%
More